123 related articles for article (PubMed ID: 34998121)
61. Structure-based design of novel boronic acid-based inhibitors of autotaxin.
Albers HM; Hendrickx LJ; van Tol RJ; Hausmann J; Perrakis A; Ovaa H
J Med Chem; 2011 Jul; 54(13):4619-26. PubMed ID: 21615078
[TBL] [Abstract][Full Text] [Related]
62. Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways.
Zhao J; He D; Berdyshev E; Zhong M; Salgia R; Morris AJ; Smyth SS; Natarajan V; Zhao Y
Biochem J; 2011 Oct; 439(1):45-55. PubMed ID: 21696367
[TBL] [Abstract][Full Text] [Related]
63. Autotaxin in liver fibrosis.
Ikeda H; Yatomi Y
Clin Chim Acta; 2012 Nov; 413(23-24):1817-21. PubMed ID: 22820036
[TBL] [Abstract][Full Text] [Related]
64. Substituted imidazo[2,3-alpha]pyridine-2-carbamate anthelmintics.
Bochis RJ; Olen LE; Waksmunski FS; Mrozik H; Eskola P; Kulsa P; Wilks G; Taylor JE; Egerton JR; Ostlind DA; Olson G
J Med Chem; 1981 Dec; 24(12):1518-21. PubMed ID: 7310830
[TBL] [Abstract][Full Text] [Related]
65. Structure-Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode.
Miller LM; Keune WJ; Castagna D; Young LC; Duffy EL; Potjewyd F; Salgado-Polo F; Engel García P; Semaan D; Pritchard JM; Perrakis A; Macdonald SJ; Jamieson C; Watson AJ
J Med Chem; 2017 Jan; 60(2):722-748. PubMed ID: 27982588
[TBL] [Abstract][Full Text] [Related]
66. Optimization of a pipemidic acid autotaxin inhibitor.
Hoeglund AB; Bostic HE; Howard AL; Wanjala IW; Best MD; Baker DL; Parrill AL
J Med Chem; 2010 Feb; 53(3):1056-66. PubMed ID: 20041668
[TBL] [Abstract][Full Text] [Related]
67. Computer Aided Drug Design Approaches for Identification of Novel Autotaxin (ATX) Inhibitors.
Vrontaki E; Melagraki G; Kaffe E; Mavromoustakos T; Kokotos G; Aidinis V; Afantitis A
Curr Med Chem; 2016; 23(17):1708-24. PubMed ID: 26997151
[TBL] [Abstract][Full Text] [Related]
68. Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study.
Lončar B; Perin N; Mioč M; Boček I; Grgić L; Kralj M; Tomić S; Stojković MR; Hranjec M
Eur J Med Chem; 2021 May; 217():113342. PubMed ID: 33751978
[TBL] [Abstract][Full Text] [Related]
69. Short hairpin RNA targeting autotaxin reduces human gastric carcinoma AGS cell proliferative, migratory and invasive capabilities in vitro and causes tumor regression in vivo.
Chen Z; Huang Y; Shen X; Guo J; Zhu G; Dralle H; Hoang-Vu C
Oncol Rep; 2013 Mar; 29(3):1087-93. PubMed ID: 23258351
[TBL] [Abstract][Full Text] [Related]
70. Role of the Autotaxin-LPA Pathway in Dexamethasone-Induced Fibrotic Responses and Extracellular Matrix Production in Human Trabecular Meshwork Cells.
Honjo M; Igarashi N; Nishida J; Kurano M; Yatomi Y; Igarashi K; Kano K; Aoki J; Aihara M
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):21-30. PubMed ID: 29305605
[TBL] [Abstract][Full Text] [Related]
71. Development of a Novel Intraocular-Pressure-Lowering Therapy Targeting ATX.
Nagano N; Honjo M; Kawaguchi M; Nishimasu H; Nureki O; Kano K; Aoki J; Komatsu T; Okabe T; Kojima H; Nagano T; Aihara M
Biol Pharm Bull; 2019; 42(11):1926-1935. PubMed ID: 31685776
[TBL] [Abstract][Full Text] [Related]
72. Establishment of a novel, cell-based autotaxin assay.
Dobersalske C; Grundmann M; Timmermann A; Theisen L; Kölling F; Harris RC; Fuerstner C; Becker MS; Wunder F
Anal Biochem; 2021 Oct; 630():114322. PubMed ID: 34343482
[TBL] [Abstract][Full Text] [Related]
73. Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation.
Park GY; Lee YG; Berdyshev E; Nyenhuis S; Du J; Fu P; Gorshkova IA; Li Y; Chung S; Karpurapu M; Deng J; Ranjan R; Xiao L; Jaffe HA; Corbridge SJ; Kelly EA; Jarjour NN; Chun J; Prestwich GD; Kaffe E; Ninou I; Aidinis V; Morris AJ; Smyth SS; Ackerman SJ; Natarajan V; Christman JW
Am J Respir Crit Care Med; 2013 Oct; 188(8):928-40. PubMed ID: 24050723
[TBL] [Abstract][Full Text] [Related]
74. Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors.
Cui P; Tomsig JL; McCalmont WF; Lee S; Becker CJ; Lynch KR; Macdonald TL
Bioorg Med Chem Lett; 2007 Mar; 17(6):1634-40. PubMed ID: 17257836
[TBL] [Abstract][Full Text] [Related]
75. Development of autotaxin inhibitors: A series of tetrazole cinnamides.
Thomson CG; Le Grand D; Dowling M; Beattie D; Elphick L; Faller M; Freeman M; Hardaker E; Head V; Hemmig R; Hill J; Lister A; Pascoe D; Rieffel S; Shrestha B; Steward O; Zink F
Bioorg Med Chem Lett; 2021 Jan; 31():127663. PubMed ID: 33160025
[TBL] [Abstract][Full Text] [Related]
76. Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion.
Saunders LP; Ouellette A; Bandle R; Chang WC; Zhou H; Misra RN; De La Cruz EM; Braddock DT
Mol Cancer Ther; 2008 Oct; 7(10):3352-62. PubMed ID: 18852138
[TBL] [Abstract][Full Text] [Related]
77. Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer.
Jinno N; Yoshida M; Hayashi K; Naitoh I; Hori Y; Natsume M; Kato A; Kachi K; Asano G; Atsuta N; Sahashi H; Kataoka H
Cancer Sci; 2021 Feb; 112(2):668-678. PubMed ID: 33053268
[TBL] [Abstract][Full Text] [Related]
78. Osteoclast-Derived Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss.
Flammier S; Peyruchaud O; Bourguillault F; Duboeuf F; Davignon JL; Norman DD; Isaac S; Marotte H; Tigyi G; Machuca-Gayet I; Coury F
Arthritis Rheumatol; 2019 Nov; 71(11):1801-1811. PubMed ID: 31162832
[TBL] [Abstract][Full Text] [Related]
79. Autotaxin stimulates LPA2 receptor in macrophages and exacerbates dextran sulfate sodium-induced acute colitis.
Wang Z; Shi W; Tian D; Qin H; Vallance BA; Yang H; Yu HB; Yu Q
J Mol Med (Berl); 2020 Dec; 98(12):1781-1794. PubMed ID: 33128578
[TBL] [Abstract][Full Text] [Related]
80. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
